同时FDA文件提到接受普拉格雷治疗的患者相对接受氯比格雷治疗的患者更容易患上癌症，虽然目前不清楚是否由于使用了普拉格雷而导致癌症的产生。

The FDA staff also notes that patients who received prasugrel were more likely to develop cancer than those who took Plavix, though it's not clear whether prasugrel actually raises the risk of cancer.

youdao

同时FDA文件提到接受普拉格雷治疗的患者相对接受氯比格雷治疗的患者更容易患上癌症，虽然目前不清楚是否由于使用了普拉格雷而导致癌症的产生。

The FDA staff also notes that patients who received prasugrel were more likely to develop cancer than those who took Plavix, though it's not clear whether prasugrel actually raises the risk of cancer.

youdao